BIOMAT Database Logo BIOMAT Database Logo

Effect of carbazochrome salicylate on transplacental transmission of fetal erythrocytes. 1966

R H Messer, and W H Pearse, and H Keenan

UI MeSH Term Description Entries
D008431 Maternal-Fetal Exchange Exchange of substances between the maternal blood and the fetal blood at the PLACENTA via PLACENTAL CIRCULATION. The placental barrier excludes microbial or viral transmission. Transplacental Exposure,Exchange, Maternal-Fetal,Exposure, Transplacental,Maternal Fetal Exchange
D010920 Placenta A highly vascularized mammalian fetal-maternal organ and major site of transport of oxygen, nutrients, and fetal waste products. It includes a fetal portion (CHORIONIC VILLI) derived from TROPHOBLASTS and a maternal portion (DECIDUA) derived from the uterine ENDOMETRIUM. The placenta produces an array of steroid, protein and peptide hormones (PLACENTAL HORMONES). Placentoma, Normal,Placentome,Placentas,Placentomes
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D002199 Capillary Permeability The property of blood capillary ENDOTHELIUM that allows for the selective exchange of substances between the blood and surrounding tissues and through membranous barriers such as the BLOOD-AIR BARRIER; BLOOD-AQUEOUS BARRIER; BLOOD-BRAIN BARRIER; BLOOD-NERVE BARRIER; BLOOD-RETINAL BARRIER; and BLOOD-TESTIS BARRIER. Small lipid-soluble molecules such as carbon dioxide and oxygen move freely by diffusion. Water and water-soluble molecules cannot pass through the endothelial walls and are dependent on microscopic pores. These pores show narrow areas (TIGHT JUNCTIONS) which may limit large molecule movement. Microvascular Permeability,Permeability, Capillary,Permeability, Microvascular,Vascular Permeability,Capillary Permeabilities,Microvascular Permeabilities,Permeabilities, Capillary,Permeabilities, Microvascular,Permeabilities, Vascular,Permeability, Vascular,Vascular Permeabilities
D004912 Erythrocytes Red blood cells. Mature erythrocytes are non-nucleated, biconcave disks containing HEMOGLOBIN whose function is to transport OXYGEN. Blood Cells, Red,Blood Corpuscles, Red,Red Blood Cells,Red Blood Corpuscles,Blood Cell, Red,Blood Corpuscle, Red,Erythrocyte,Red Blood Cell,Red Blood Corpuscle
D005260 Female Females
D006490 Hemostatics Agents acting to arrest the flow of blood. Absorbable hemostatics arrest bleeding either by the formation of an artificial clot or by providing a mechanical matrix that facilitates clotting when applied directly to the bleeding surface. These agents function more at the capillary level and are not effective at stemming arterial or venous bleeding under any significant intravascular pressure. Antihemorrhagic,Hemostatic,Antihemorrhagics
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

R H Messer, and W H Pearse, and H Keenan
Effect of citrus bioflavonoid, carbazochrome salicylate, and ascorbic acid on the transplacental passage of fetal erythrocytes. Studies during normal pregnancy.
March 1967, Obstetrics and gynecology,
R H Messer, and W H Pearse, and H Keenan
TRANSPLACENTAL TRANSMISSION OF FETAL ERYTHROCYTES.
August 1963, American journal of obstetrics and gynecology,
R H Messer, and W H Pearse, and H Keenan
Transplacental transmission of fetal erythrocytes with demonstration of fetal hemoglobin in maternal circulation.
June 1956, Obstetrics and gynecology,
R H Messer, and W H Pearse, and H Keenan
[CONSIDERATIONS ON THE TRANSPLACENTAL PASSAGE OF FETAL ERYTHROCYTES].
May 1964, Rivista di ostetricia e ginecologia,
R H Messer, and W H Pearse, and H Keenan
Transplacental passage of fetal erythrocytes during pregnancy.
August 1966, Obstetrics and gynecology,
R H Messer, and W H Pearse, and H Keenan
Bleeding episode associated with carbazochrome salicylate.
July 1972, Canadian Medical Association journal,
R H Messer, and W H Pearse, and H Keenan
Successful non-surgical uses of carbazochrome salicylate.
November 1958, American practitioner and digest of treatment,
R H Messer, and W H Pearse, and H Keenan
Comparative blood loss in hysterectomies. An apparent effect of carbazochrome salicylate on postoperative infections.
March 1972, Obstetrics and gynecology,
R H Messer, and W H Pearse, and H Keenan
Observations on the use of carbazochrome salicylate in surgical practice.
December 1962, Clinical medicine (Northfield, Ill.),
R H Messer, and W H Pearse, and H Keenan
Carbazochrome salicylate therapy in hereditary hemorrhagic telangiectasia.
July 1959, New York state journal of medicine,
Copied contents to your clipboard!